Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis
- 25 February 2020
- journal article
- research article
- Published by Springer Nature in Journal of Neurology
- Vol. 267 (6) , 1699-1708
Abstract
Neurofilament light chain protein (NfL) is currently the most accurate cerebrospinal fluid (CSF) biomarker in amyotrophic lateral sclerosis (ALS) in terms of both diagnostic and prognostic value, but the mechanism underlying its increase is still a matter of debate. Similarly, emerging CSF biomarkers of neurodegeneration and neuroinflammation showed promising results, although further studies are needed to clarify their clinical and pathophysiological roles. In the present study we compared the diagnostic accuracy of CSF NfL, phosphorylated (p)-tau/total (t)-tau ratio, chitinase-3-like protein 1 (YKL-40) and chitotriosidase 1 (CHIT1), in healthy controls (n = 43) and subjects with ALS (n = 80) or ALS mimics (n = 46). In ALS cases, we also investigated the association between biomarker levels and clinical variables, the extent of upper motor neuron (UMN) and lower motor neuron (LMN) degeneration, and denervation activity through electromyography (EMG). ALS patients showed higher levels of CSF NfL, YKL-40, CHIT1, and lower values of p-tau/t-tau ratio compared to both controls and ALS mimics. Among all biomarkers, NfL yielded the highest diagnostic performance (> 90% sensitivity and specificity) and was the best predictor of disease progression rate and survival in ALS. NfL levels showed a significant correlation with the extent of LMN involvement, whereas YKL-40 levels increased together with the number of areas showing both UMN and LMN damage. EMG denervation activity did not correlate with any CSF biomarker change. These findings confirm the highest value of NfL among currently available CSF biomarkers for the diagnostic and prognostic assessment of ALS and contribute to the understanding of the pathophysiological and electrophysiological correlates of biomarker changes.Keywords
Funding Information
- Ministero della Salute ("Ricerca Corrente")
This publication has 31 references indexed in Scilit:
- Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?Journal of Neurology, Neurosurgery & Psychiatry, 2019
- CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrumNeurology, 2018
- Significance of CSF NfL and tau in ALSJournal of Neurology, 2018
- Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral SclerosisNeuropathology and Applied Neurobiology, 2018
- Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosisNeurology, 2018
- Neurofilament markers for ALS correlate with extent of upper and lower motor neuron diseaseNeurology, 2017
- Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patientsJournal of Neurology, Neurosurgery & Psychiatry, 2015
- CSF neurofilament light chain reflects corticospinal tract degeneration in ALSAnnals of Clinical and Translational Neurology, 2015
- Electrodiagnostic criteria for diagnosis of ALSClinical Neurophysiology, 2008
- El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosisAmyotrophic Lateral Sclerosis, 2000